PHAXIAM THERAPEUTICS S.A.

All News PHAXIAM Therapeutics S.A.

Equities

PHXM

FR001400K4B1

End-of-day quote Euronext Paris Other stock markets 06:00:00 2024-05-19 pm EDT			5-day change	1st Jan Change
3.055 ^EUR	0.00%		+0.99%	-33.59%

Apr. 15	Phaxiam initiates trial in infective endocarditis	CF
Apr. 15	PHAXIAM Therapeutics Announces Enrolment of First Patient in the Phase 1 Study for the Treatment of Endocarditis Infections Caused by Staphylococcus Aureus	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

PHAXIAM provides Business and Financial Update for the First Quarter of 2024	May. 15	GL
Phaxiam initiates trial in infective endocarditis	Apr. 15	CF
PHAXIAM Therapeutics announces enrolment of the first patient in the phase 1 study for the treatment of endocarditis infections caused by Staphylococcus aureus	Apr. 15	GL
PHAXIAM Therapeutics Announces Enrolment of First Patient in the Phase 1 Study for the Treatment of Endocarditis Infections Caused by Staphylococcus Aureus	Apr. 15	CI
PHAXIAM Therapeutics announces filing of its 2023 Universal Registration Document (URD)	Apr. 05	GL
Transcript : PHAXIAM Therapeutics S.A., Q4 2023 Earnings Call, Mar 21, 2024	Mar. 21
PHAXIAM Announces 2023 Full-Year Results and Provides Business Update	Mar. 20	GL
PHAXIAM Therapeutics S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 20	CI
PHAXIAM Therapeutics Completes Delisting of ADS From Nasdaq	Mar. 11	MT
Phaxiam Therapeutics Delists from Nasdaq Capital Market	Mar. 11	MT
PHAXIAM Therapeutics announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock Market	Mar. 11	GL
PHAXIAM Therapeutics S.A.(NasdaqCM:PHXM) dropped from NASDAQ Composite Index	Mar. 07	CI
ADRs Slump, Quoin Pharmaceuticals Ltd. Declines 48.3%	Mar. 05	DJ
ADRs Slump; Jianpu Technology Declines 62%	Feb. 21	DJ
Global markets live: BAE Systems, HSBC, Nvidia, Tesla, Boeing...	Feb. 21
Phaxiam to delist ADS from Nasdaq in March	Feb. 21	CF
PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital Market	Feb. 20	GL
PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital Market	Feb. 20	AQ
PHAXIAM Therapeutics S.A.(NasdaqCM:PHXM) added to NASDAQ Composite Index	23-06-29	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Stock Market
Equities
PHXM Stock
News PHAXIAM Therapeutics S.A.

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.

BENEFIT NOW